Norovirus Surge Triggers Stay-Home Orders Amid Concerns Over New mRNA Vaccine

In England and Wales, norovirus cases have increased by 16% in just two weeks, owing primarily to the GII.17 variant known as ‘Kawasaki.’ Health officials advise people to stay home for 48 hours after symptoms such as vomiting and diarrhea have subsided to avoid spreading the highly contagious bug. The virus is particularly dangerous for hospitals, where outbreaks can result in ward closures. Moderna is now testing a novel mRNA vaccine that shows potential for inducing a significant immune response to the virus.

Editor’s Note: The recent spike in norovirus occurrences in England and Wales has prompted health experts to encourage people to stay at home for 48 hours after symptoms have subsided in order to contain the virus’s spread. While the objective is to prevent epidemics, such stay-at-home orders can have serious consequences, particularly for workers who do not have sick leave benefits, potentially leading to missed income and job security problems. The pressure on families to conform while also handling everyday tasks exemplifies the persistent contradiction between public health efforts and real-world effects.

On another front, the unveiling of Moderna’s new norovirus mRNA vaccine raises old worries, particularly in light of the controversy surrounding mRNA technology employed during the COVID-19 pandemic. While Moderna says that this new vaccination stimulates a “strong immune response,” it is difficult to ignore the history of bad effects documented by those who received the COVID-19 vaccine, such as myocarditis and other inflammatory disorders. [See also: Study Reveals COVID mRNA Vaccine Components Remain in Blood for Up to 28 Days, Unveiling Hidden Risks: mRNA COVID-19 Vaccines and Cancer, Study: Autoimmune Diseases Linked to mRNA COVID-19 Vaccines]

Read Original Article